BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23135967)

  • 1. Genetic testing in the contemporary diagnosis of cardiomyopathy.
    Sturm AC
    Curr Heart Fail Rep; 2013 Mar; 10(1):63-72. PubMed ID: 23135967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic evaluation of familial cardiomyopathy.
    Judge DP; Johnson NM
    J Cardiovasc Transl Res; 2008 Jun; 1(2):144-54. PubMed ID: 20559909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Hershberger RE; Cowan J; Morales A; Siegfried JD
    Circ Heart Fail; 2009 May; 2(3):253-61. PubMed ID: 19808347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing.
    Louis C; Calamaro E; Vinocur JM
    Curr Opin Cardiol; 2018 Jan; 33(1):78-86. PubMed ID: 29059074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the diagnosis and management of familial dilated cardiomyopathy.
    Fatkin D;
    Heart Lung Circ; 2007 Feb; 16(1):19-21. PubMed ID: 17188933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetics of inherited cardiomyopathies].
    Richard P; Fressart V; Charron P; Hainque B
    Pathol Biol (Paris); 2010 Oct; 58(5):343-52. PubMed ID: 19942368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and genetic aspects of hypertrophic and dilated cardiomyopathy].
    Meder B; Katus HA
    Internist (Berl); 2012 Apr; 53(4):408-14, 417-8. PubMed ID: 22388920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
    Charron P; Arad M; Arbustini E; Basso C; Bilinska Z; Elliott P; Helio T; Keren A; McKenna WJ; Monserrat L; Pankuweit S; Perrot A; Rapezzi C; Ristic A; Seggewiss H; van Langen I; Tavazzi L;
    Eur Heart J; 2010 Nov; 31(22):2715-26. PubMed ID: 20823110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
    van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
    Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
    Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
    Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Testing for Cardiomyopathies in Clinical Practice.
    Ingles J; Bagnall RD; Semsarian C
    Heart Fail Clin; 2018 Apr; 14(2):129-137. PubMed ID: 29525642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death].
    Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA
    Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.
    Wynn J; Holland DT; Duong J; Ahimaz P; Chung WK
    J Genet Couns; 2018 Aug; 27(4):927-934. PubMed ID: 29243008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in cardiomyopathies: an update on indications and benefits.
    Aleksova N; Rutberg J; Green M; Haddad H
    Curr Opin Cardiol; 2017 Mar; 32(2):189-195. PubMed ID: 27861187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of Predictive Genetic Testing and Cardiac Evaluation for Children at Risk for an Inherited Arrhythmia or Cardiomyopathy.
    Christian S; Atallah J; Clegg R; Giuffre M; Huculak C; Dzwiniel T; Parboosingh J; Taylor S; Somerville M
    J Genet Couns; 2018 Feb; 27(1):124-130. PubMed ID: 28699125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
    Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic impact of genetic testing in hypertrophic cardiomyopathy: The story of two families.
    Lorca R; Martín M; Gómez J; Junquera MR; Morís C; Coto E; Reguero JJR
    Int J Cardiol; 2016 Feb; 205():161-162. PubMed ID: 26736093
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of genetics in the clinical evaluation of cardiomyopathy.
    Judge DP
    JAMA; 2009 Dec; 302(22):2471-6. PubMed ID: 19996403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy and planned in vitro fertilization. Genetic testing and clinical evaluation.
    Zhu Hu J; Xiang Li J; Hong K; Xin Hu J; Brugada P; Shu Cheng X
    Herz; 2012 Jun; 37(4):447-52. PubMed ID: 22301726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.